Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker LSTA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 9, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 9, 2026 | LSTA Lisata Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 9, 2026 | LSTA Lisata Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 14, 2026 | LSTA Lisata Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 17, 2026 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 17, 2026 | LSTA Lisata Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Sep 17, 2026 | LSTA Lisata Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 17, 2026 | LSTA Lisata Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 17, 2026 | LSTA Lisata Therapeutics, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 17, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 4, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 4, 2026 | LSTA Lisata Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 4, 2026 | LSTA Lisata Therapeutics, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Jul 24, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 24, 2026 | LSTA Lisata Therapeutics, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 17, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 9, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 1, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 29, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 4, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 15, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 3, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 9, 2026 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 9, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 27, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 27, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 21, 2026 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 21, 2026 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 6, 2025 | LSTA Lisata Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 14, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 8, 2025 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 7, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 7, 2025 | LSTA Lisata Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 15, 2025 | LSTA Lisata Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 26, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 17, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 17, 2025 | LSTA Lisata Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 13, 2025 | LSTA Lisata Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 10, 2025 | LSTA Lisata Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 8, 2025 | LSTA Lisata Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 27, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2025 | LSTA Lisata Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 23, 2025 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 3, 2024 | LSTA Lisata Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 12, 2024 | LSTA Lisata Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | LSTA Lisata Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
48 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances